Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
JMIR Research Protocols|March 20, 2019
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE StudyEva Clemens, Annelot Jm Meijer, Linda Broer, et al.The Pharmacogenomics Journal|November 1, 2019
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE StudyEva Clemens, Linda Broer, Thorsten Langer, et al.International Journal of Cancer|September 16, 2023
The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortiumSergiu Scobioala, Ross Parfitt, Peter Matulat, et al.Data in Brief|September 17, 2020
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE datasetThorsten Langer, Eva Clemens, Linda Broer, et al.European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort studyThorsten Langer, Eva Clemens, Linda Broer, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.Pageof 6